Understanding the bone marrow microenvironment in hematologic malignancies: A focus on chemokine, integrin, and extracellular vesicle signaling-Reference-Cited by-同舟云学术

Understanding the bone marrow microenvironment in hematologic malignancies: A focus on chemokine, integrin, and extracellular vesicle signaling

Published:2017-10-03 Issue:6-7 Volume:34 Page:365-378
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Sison Edward Allan Racela¹,Kurre Peter²,Kim Yong-Mi³

Affiliation:

1. Department of Pediatrics, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, Texas, USA

2. Department of Pediatrics, Doernbecher Children's Hospital, Oregon Health and Science University, Portland, Oregon, USA

3. Department of Pediatrics, Children's Hospital of Los Angeles, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA

Publisher

Informa UK Limited

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/08880018.2017.1395938

Reference105 articles.

1. The bone marrow microenvironment and leukemia: biology and therapeutic targeting

2. Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia

3. Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells

4. Analysis of the mechanism of adhesion of precursor-B acute lymphoblastic leukemia cells to bone marrow fibroblasts

5. Coordinate regulation of residual bone marrow function by paracrine trafficking of AML exosomes

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia;Frontiers in Oncology;2021-12-01

2. In vitro and in vivo effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA‑4, in B‑cell acute lymphoblastic leukemia;Experimental and Therapeutic Medicine;2021-11-15

3. Cadherins, Selectins, and Integrins in CAM-DR in Leukemia;Frontiers in Oncology;2020-12-10

4. Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment;International Journal of Molecular Sciences;2020-08-28

5. Integrin-Mediated Adhesion and Chemoresistance of Acute Lymphoblastic Leukemia Cells Residing in the Bone Marrow or the Central Nervous System;Frontiers in Oncology;2020-05-22